Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Together, these studies suggest that experimenting with doses in excess of 1 mg may produce very severe side effects in test subjects
Riluzole remains the main approved therapy for ALS, despite yielding only modest survival gains through partial attenuation of glutamatergic excitotoxicity [7073]
Important: this is not FDA approval This is the part the headlines often blur
doi: 10.1007/s11356-020-08564-z 43 VincentMJKozalJSThompsonWJMaierADotsonGSBestEAet al
Epidemiology of Cardiovascular Disease in China: Current Features and Implications
US$ 29.89
US$ 21.71
US$ 27.06
US$ 29.04
US$ 24.25
US$ 22.14
US$ 20.45
US$ 29.59
